|1.||Qian, Zhong-Ji: 1 article (06/2013)|
|2.||Kang, Kyong-Hwa: 1 article (06/2013)|
|3.||Kim, Daekyung: 1 article (06/2013)|
|4.||Ryu, Bomi: 1 article (06/2013)|
|5.||Karadeniz, Fatih: 1 article (06/2013)|
|6.||Kim, Se-Kwon: 1 article (06/2013)|
|7.||Mitton, Bryan: 1 article (12/2006)|
|8.||Waggoner, Jason R: 1 article (12/2006)|
|9.||Kranias, Evangelia G: 1 article (12/2006)|
|10.||Rodriguez, Patricia: 1 article (12/2006)|
|1.||Hepatocellular Carcinoma (Hepatoma)
04/01/2004 - "Protein phosphatase inhibitor-1 mRNA expression correlates with neoplastic transformation of epithelial liver cells and progression of hepatocellular carcinomas."
04/01/2000 - "Increased expression of NIPP-1 mRNA correlates positively with malignant phenotype in rat hepatomas."
04/01/2000 - "The levels of NIPP-1 mRNA were closely correlated with malignant phenotype of rat ascites hepatomas, suggesting that NIPP-1 is tightly linked to malignant phenotype in hepatomas."
06/01/2013 - "Therefore, it could be suggested that NIPP-1 has potential to be used in anti-fibrosis treatment. "
06/01/2013 - "The treatment of NIPP-1 and NIPP-2 on TGF-β1 induced LX-2 cells alleviated hepatic fibrosis. "
06/01/2013 - "TGF-β1 activated fibrosis in LX-2 cells was examined in the presence or absence of purified peptides NIPP-1 and NIPP-2. "
|4.||Type 2 Diabetes Mellitus (MODY)
02/01/1999 - "Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients."
02/01/1999 - "In 70 insulin-resistant Danish NIDDM patients, mutational analysis by reverse transcription-polymerase chain reaction-single strand conformation polymorphism-heteroduplex analysis was performed on genomic DNA or skeletal muscle-derived cDNAs encoding glycogenin, protein phosphatase inhibitor-1, phophatase targeting to glycogen, protein kinase B-alpha and -beta, and the phosphoinositide-dependent protein kinase-1. "
|1.||Messenger RNA (mRNA)
|2.||Proto-Oncogene Proteins c-akt (Protein Kinase B)
|6.||DNA (Deoxyribonucleic Acid)